Regulating Together for Autism
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two programs designed to help children with autism manage their emotions. The Achieving Independence and Mastery in School (AIMS) program focuses on enhancing school skills, while the Regulating Together (RT) program directly targets emotion regulation. The trial aims to determine which approach better supports emotional and social outcomes. Children with autism who struggle to regulate their emotions may be well-suited for this study. As an unphased trial, it offers participants a unique opportunity to contribute to innovative approaches that could significantly enhance emotional and social skills in children with autism.
Will I have to stop taking my current medications?
The trial requires that families keep prescribed medications stable, so you won't need to stop taking your current medications.
What prior data suggests that the Regulating Together intervention is safe for youth with autism?
A previous study tested the Achieving Independence and Mastery in School (AIMS) program with 21 middle school students with autism. The results showed that participants found the program easy to use and were satisfied with it. No safety concerns arose, indicating that AIMS is well-tolerated.
A telehealth pilot study examined the practicality and acceptability of the Regulating Together (RT) program. Although specific safety details were not mentioned, the study focused on helping autistic children and teens manage their emotions, and no safety issues were noted.
Both AIMS and RT appear safe, as available research reports no negative effects. This suggests these programs are likely well-tolerated by participants.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for autism because they offer new approaches to managing the condition. The "Achieving Independence and Mastery in School" (AIMS) program focuses on improving academic functioning and organizational skills, which are often challenging for individuals with autism. On the other hand, "Regulating Together" (RT) targets emotion dysregulation, a common issue not always addressed by typical behavioral therapies. Unlike standard treatments that may primarily focus on behavioral interventions, these programs aim to equip participants with specific skills to enhance their daily functioning and emotional well-being, potentially leading to a more holistic improvement in quality of life.
What evidence suggests that this trial's treatments could be effective for autism?
Research has shown that the Achieving Independence and Mastery in School (AIMS) program, a treatment option in this trial, helps young people with autism improve skills needed for school success. Studies found that students in AIMS demonstrated small to moderate improvements in managing tasks and organizing activities after the program.
For Regulating Together (RT), another treatment option in this trial, studies suggest it helps young people with autism better manage their emotions. Participants in those studies showed improvements in handling emotional reactions, reducing irritability, and controlling behavior. These findings highlight RT's potential in helping participants manage their emotions more effectively. Overall, both programs provide valuable support for young people with autism in handling school and emotional challenges.13678Who Is on the Research Team?
Rebecca Shaffer
Principal Investigator
Children's Hospital Medical Center, Cincinnati
Are You a Good Fit for This Trial?
This trial is for English-speaking caregivers and their children with autism spectrum disorder (ASD) who are 11-12 years old, have functional verbal communication, an IQ score of 65 or higher, and issues with emotion regulation. Families must commit to twice-weekly sessions and keep current medications stable. Children with major sensory impairments, recent psychosocial interventions, a history of serious aggression, or other major neuropsychiatric illnesses are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Baseline assessments are conducted
Treatment
Participants receive 5 weeks of intervention, twice per week
Post Active Treatment
Post-treatment assessments including semi-structured interviews
Post Generalization
Assessments to evaluate generalization of skills
Follow-up
Final outcome visit to monitor long-term effects
What Are the Treatments Tested in This Trial?
Interventions
- Achieving Independence and Mastery in School (AIMS)
- Regulating Together (RT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital Medical Center, Cincinnati
Lead Sponsor
United States Department of Defense
Collaborator
University of Alabama at Birmingham
Collaborator